Lv4
700 积分 2023-10-11 加入
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
13小时前
待确认
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
13小时前
待确认
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
17小时前
待确认
体内嵌合抗原受体T细胞（in vivo CAR-T）研究进展及非临床研究一般考虑
18小时前
待确认
体内嵌合抗原受体T细胞 ( in vivo CAR-T）研究进展及非临床研究一般考虑
18小时前
已完结
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
1天前
待确认
Optimizing initial therapy in DLBCL
4天前
已完结
Diffuse Large B-Cell Lymphoma
4天前
已完结
Autosomal Dominant Polycystic Kidney Disease
5天前
已完结
Sickle Cell Disease
5天前
已完结
皖公网安备34019202002308
